About the ITR

ITR = Investigational Therapeutics Resource

The Investigational Trials Resource (ITR) is an organizational unit within the Helen Diller Family Comprehensive Cancer Center (HDFCCC) which was launched in 2007 with the goal of centralizing and streamlining the HDFCCC’s clinical research infrastructure and increasing patient accrual. The ITR is responsible for the entire clinical research enterprise within the HDFCCC, including oversight of the Clinical Research Support Office, Data and Safety Monitoring, and Protocol Review and Monitoring System, as well as providing interface for interactions of the Clinical Research enterprise with the Biostatistics Core and Translational Informatics Core. Its Director is Dr. Eric Small, the Associate Director for Clinical Sciences and Deputy Director of the HDFCCC. Dr. Small reports to the HDFCCC Director, Dr. Frank McCormick.

The ITR:

• Provides centralized oversight, review and prioritization of cancer-related clinical research activities at UCSF
• Provides infrastructure and resources to support and streamline clinical and translational research activity within the HDFCCC
• Is responsible for all clinical shared resources and activities in the HDFCCC
• Is guided by the ITR Steering Committee
• Has oversight over three distinct units:
  • Protocol Review and Monitoring System (PRMS)
  • Data and Safety Monitoring (DSM)
  • Clinical Research Support Office (CRSO).